FDA Inspection 1234443 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on September 30, 2021 in Radeberg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 30, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Radeberg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)